Abstract
The medical devices when they implanted or inserted into human body become the sites of competition between host cell integration and microbial adhesion while exerting the intended purpose like salvage of normal functions of vital organs. Different approaches either to enhance the efficiency of certain antimicrobial agents or to disrupt the basic physiology of the pathogenic microorganisms, including novel small molecules and antipathogenic drugs are already being employed to control microbial colonization and subsequent biofilm formation onto the medical devices. Recently, various lipid-and polymer-based drug delivery carriers are also investigated for applying antibiofilm coating onto the medical devices especially over catheters. To ensure systematic release of antimicrobial agents into the surrounding vicinity of an implanted medical device and, furthermore, provide sufficient initial and subsequent antimicrobial substance release, the antimicrobial substance are being incorporated into a controlled releasing polymer system, and then used to coat over medical devices. This book chapter summarizes the major and/breakthrough inventions disclosed in patent literature as well as in research papers showing the potential of lipid-and polymer-based drug delivery carriers to eradicate microbial biofilm causing medical device-related infections. With this coverage, this book chapter therefore provides a range of lipid and polymer-based drug delivery carrier is available for the medical scientist to develop a medical device with antibiofilm property.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelkefi A, Achour W, Ben OT, Ladeb S, Torjman L, Lakhal A, Ben HA, Hsairi M, Ben AA (2007) Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol 5:273–278
Ahmed K, Muiruri PW, Jones GH, Scott MJ, Jones MN (2001) The effect of grafted poly(ethylene glycol) on the electrophoretic properties of phospholipid liposomes and their adsorption to bacterial biofilms. Colloids Surf A Physicochem Eng Asp 194:287–296
Ahmed K, Gribbon PN, Jones MN (2002) The application of confocal microscopy to the study of liposome adsorption onto bacterial biofilms. J Liposome Res 12:285–300
Ahmed K, Jones MN (2003) The effect of shear on the desorption of liposomes adsorbed to bacterial biofilms. J Liposome Res 13(2):187–197
Ahuja A, Ali J, Rahman S (2006) Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation. Pharmazie 61:25–29
Allen TM, Hancen C, Martin F, Redemann C, Yau-Young A (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36
Al-Mobaireek KF (2001) Ulcerative colitis and chronic granulomatous disease: a case report and review of the literature. Saudi J Gastroenterol 7:119–121
al-Orainey IO, Bashandi AM, Saeed EN (1990) Failure of ciprofloxacin to eradicate brucellosis in experimental animals. J Chemother 2:380–383
Alt V, Bitschnau A, Osterling J, Sewing A, Meyer C, Kraus R, Meissner SA, Wenisch S, Domann E, Schnettler R (2006) The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 27:4627–4634
Ambrose CG, Gogola GR, Clyburn TA, Raymond AK, Peng AS, Mikos AG (2003) Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin Orthop 415:279–285
An YH, Dickinson RB, Doyle RJ (2000a) Mechanisms of bacterial adhesion and pathogenesis of implant and tissue infections. In: An YH, Friedman RJ (eds) Handbook of bacterial adhesion: principles, methods, and applications. Humana Press, Totowa, pp 1–27
An YH, Blair BK, Martin KL, Friedman RJ (2000b) Macromolecule surface coating for preventing bacterial adhesion. In: An YH, Friedman RJ (eds) Handbook of bacterial adhesion. Humana Press, Totowa, pp 609–625
Anaissie E, Penzak S, Dignani C (2002) The hospital water supply as a source of nosocomial infections. Arch Intern Med 162:1483–1492
Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100
Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O (1996) Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from aprospective, randomized trial. Crit Care Med 24:1482–1489
Aviv M, Berdicevsky I, Zilberman M (2007) Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J Biomed Mater Res A 83:10–19
Bach A, Schmidt H, Bottiger B, Schreiber B, Bohrer H, Motsch J, Martin E, Sonntag HG (1996) Retention of antibacterial activity and bacterial colonisation of antiseptic-bonded central venous catheters. J Antimicrob Chemother 37(2):315–322
Bach A, Eberhardt H, Frick A, Schmidt H, Bottinger BW, Martin E (1999) Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 27:515–520
Bakaletz LO (2007) Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J 10(Suppl):S17–S19
Bakker-Woudenberg IAJM, Schiffelers RM, ten Kate MT, Storm G, Guo L, Working P (2000) Targeting of antibiotics in bacterial infection using pegylated long-circulating liposomes. J Liposome Res 10:513–521
Bakker-Woudenberg IAJM, ten Kate MT, Guo L, Working P, Mouton JW (2001) Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother 45:1487–1492
Bakker-Woudenberg IAJM, ten Kate MT, Guo L, Working P, Mouton JW (2002) Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection. Antimicrob Agents Chemother 46:2575–2581
Bauer TW, Schils J (1999) The pathology of total joint arthroplasty. I. Mechanisms of implant fixation. Skeletal Radiol 28(8):423–432
Baumgartner JN, Yang CZ, Cooper SL (1997) Physical property of analysis and bacterial adhesion on a series of phosphonated polyurethanes. Biomaterials 18(2):831–837
Beech IB, Sunner JA, Hiraoka K (2005) Microbe-surface interactions in biofouling and biocorrosion processes. Int Microbiol 8:157–168
Bergan T, Dalhoff A, Rohwedder R (1988) Pharmacokinetics of ciprofloxacin. Infection 16(Suppl 1):3–13
Beyth N, Houri-Haddad Y, Baraness-Hadar L, Yudovin-Farber I, Domb AJ, Weiss EI (2008) Surface antimicrobial activity and biocompatibility of incorporated polyethylenimine nanoparticles. Biomaterials 29:4157–4163
Bhadra D, Bhadra S, Jain P, Jain NK (2002) Pegnology: a review of PEG-ylated systems. Pharmazie 57:5–29
Bjarnsholt T, Givskov M (2007) Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 362(1483):1213–1222
Blanchemain N, Haulon S, Boschin F, Traisnel M, Morcellet M, Martel B, Hildebrand HF (2007) Vascular prostheses with controlled release of antibiotics Part 2. In vitro biological evaluation of vascular prostheses treated by cyclodextrins. Biomol Eng 24:143–148
Boles BR, Thoendel M, Singh PK (2005) Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol 57:1210–1223
Böswald M, Lugauer S, Regenfus A, Braun GG, Martus P, Geis C, Scharf J, Bechert T, Greil J, Guggenbichler JP (1999) Reduced rates of catheter- associated infection by use of a new silver-impregnated central venous catheter. Infection 27(Suppl 1):S56–S60
Brady MJ, Lisay CM, Yurkovetskiy AV, Sawan SP (2003) Persistent silver disinfectant for the environmental control of pathogenic bacteria. Am J Infect Control 31:208–214
Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52(1):13–22
Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fievet F (2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6:866–870
Bridgett MJ, Davies MC, Denyer SP (1992) Control of staphylococcal adhesion to polystyrene surfaces by polymer surface modification with surfactants. Biomaterials 13(7):411–416
Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G (2004) Prevention of intravascular catheter-related infection with newer chlorhexidine-silver-sulfadiazine-catheters. Intensive Care Med 30:837–843
Buchholz HW, Engelbrecht H (1970) Uber die Depotwirkung einiger Antibiotica bei Vermischung mit dem Kunstharz Palacos [Depot effects of various antibiotics mixed with Palacos resins]. Chirurg 41:511–515
Buchholz HW, Gartmann HD (1972) Infection prevention and surgical management of deep insidious infection in total endoprothesis. Chirurg 43:446–453
Burd TA, Anglen JO, Lowry KJ, Hendricks KJ, Day D (2001) In vitro elution characteristics of tobramycin from bioabsorbable polycaprolactone bead. J Orthop Trauma 15:424–428
Cachia PJ, Hodges RS (2003) Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Biopolymers 71(2):141–168
Cai Y, Fan Y, Wang R, An MM, Liang BB (2009) Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. J Antimicrob Chemother 64:563–566
Carbon RT, Lugauer S, Geitner U, Regenfus A, Böswald M, Greil J, Bechert T, Simon SI, Hümmer HP, Guggenbichler JP (1999) Reducing catheter associated infections with silver-impregnated catheters in long-terms therapy of children. Infection 27(Suppl 1):S69–S73
Carmen JC, Nelson JL, Beckstead BL, Runyan CM, Robison RA, Schaap AP, Pitt WG (2004a) Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J Infect Dis 10:193–199
Carmen JC, Roeder BL, Nelson JL, Beckstead BL, Runyan CM, Schaalje GB, Robison RA, Pitt WG (2004b) Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 18:237–245
Casadevall A, Dadachova E, Pirofski LA (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2(9):695–703
Castro C, Sánchez E, Delgado A, Soriano I, Núńez P, Baro M, Perera A, Évora C (2003) Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Control Release 93:341–354
Catuogno C, Jones MN (2003) The antibacterial properties of solid supported liposomes on Streptococcus oralis biofilms. Int J Pharm 257:125–140
Chai F, Hornez JC, Blanchemain N, Neut C, Descamps M, Hildebrand HF (2007) Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics. Biomol Eng 24:510–514
Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB, Jabbouri S (2007) Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl Microbiol Biotechnol 75:125–132
Chang QY, He H, Ma ZC (2008) Efficient disinfection of Escherichia coli in water by silver loaded alumina. J Inorg Biochem 102:1736–1742
Chen JF, Lee ST (2006) Antibiotic-polymethylmethacrylate strut: an option for treating cervical pyogenic spondylitis, case report. J Neurosurg Spine 5(1):90–95
Chonn A, Semple SC, Cullis PR (1994) Protein- membrane interactions in the biological milieu. In: Op den Kamp JAF (ed) Biological membranes: structure, biogenesis and dynamics, vol 82, NATO ASI series H: cell biology. Springer, Heidelberg, pp 101–109
Christensen D, Korsholm KS, Rosenkrands I, Lindenstrøm T, Andersen P, Agger EM (2007) Cationic liposomes as vaccine adjuvants. Expert Rev Vaccines 6:785–796
Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ (1996) Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 62(8):641–646
Collin GR (1999) Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 115(6):1632–1640
Corchero JL, Villaverde A (2009) Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol 27:468–476
Cordeiro C, Wiseman DL, Lutwyche P, Uh M, Evans JC, Finlay BB, Webb MS (2000) Antibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar typhimurium intracellular infection model. Antimicrob Agents Chemother 44:533–539
Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE (1994) Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 38:2803–2809
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
Costerton JW, Montanaro L, Arciola CR (2005) Biofilm in implant infections: its production and regulation. Int J Artif Organs 28:1062–1068
Cozad A, Jones RD (2003) Disinfection and the prevention of infectious disease. Am J Infect Control 31:243–254
Crnich CJ, Maki DG (2002) The promise of novel technology for the prevention of intravascular device-related bloodstream infection, I: pathogenesis and short-term devices. Clin Infect Dis 34(9):1232–1242
Curfman GD, Morrissey S, Drazen JM (2009) The Medical Device Safety Act of 2009. N Engl J Med 360(15):1550–1551
Dalhoff A (1989) A review of quinolone pharmacokinetics. In: Fernandes PB (ed) Telesymposium on quinolones. J.R. Prous Science Publishers, Barcelona, pp 277–312
Danese PN (2002) Antibiofilm approaches: prevention of catheter colonization. Chem Biol 9:873–880
Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S (2009) Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother 64:88–93
Davenas J, Thevenard P, Philippe F, Arnaud MN (2002) Surface implantation treatments to prevent infection complications in short term devices. Biomol Eng 19(2–6):263–268
Desai NP, Hossainy SF, Hubbell JA (1992) Surface-immobilized polyethylene oxide for bacterial repellence. Biomaterials 13(7):417–420
DiTizio V, Ferguson GW, Mittelman MW, Khoury AE, Bruce AW, DiCosmo F (1998) A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 19:1877–1884
Donelli G, Francolini I (2001) Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review. J Chemother 13:595–606
Donelli G, Francolini I, Piozzi A, Di Rosa R, Marconi W (2002) New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 14:501–507
Donelli G, Francolini I, Ruggeri V, Guaglianone E, D’Ilario L, Piozzi A (2006) Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonization. J Appl Microbiol 100:615–622
Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB (2007) Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51:2733–2740
Donelli G, Guaglianone E, Martinelli A, Piozzi A, D’Ilario L, Francolini I (2009) Eurobiofilms 2009. Abstract book, First European Congress on microbial biofilms, Rome, 2–5 Sept 2009, p 82
Donowitz GR (1994) Tissue directed antibiotics and intracellular parasites: complex interactions of phagocytes, pathogens and drugs. Clin Infect Dis 19:926–930
Dunkirk SG, Gregg SL, Duran LW, Monfils JD, Haapala JE, Marcy JA, Clapper DL, Amos RA, Gurie PE (1991) Photochemical coatings for the prevention of bacterial colonization. J Biomater Appl 6(2):131–156
Easmon CSF, Crane JP (1985a) Uptake of ciprofloxacin by macrophages. J Clin Pathol 38:442–444
Easmon CSF, Crane JP (1985b) Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemother 16:67–73
Eduardo L, Bermudez M, Wu M, Young LS (1987) Intracellular killing of Mycobacterium avium complex by rifapentine and liposome encapsulated amikacin. J Infect Dis 156:510–513
Ellbogen MH, Olsen KM, Gentry-Nielsen MJ, Preheim LC (2003) Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia. J Antimicrob Chemother 51(1):83–91
Eron LJ (1985) Prevention of infection following orthopedic surgery. Antibiot Chemother 33:140–164
Esposito E, Carotta V, Scabbia A, Trombelli LD, Antona P, Menegatti E (1996) Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations. Int J Pharm 142:9–23
Finelli A, Burrows LL, DiCosmo FA, DiTizio V, Sinnadurai S, Oreopoulos DG, Khoury AE (2002) Colonization-resistant antimicrobial-coated peritoneal dialysis catheters: evaluation in a newly developed rat model of persistent Pseudomonas aeruginosa peritonitis. Perit Dial Int 22:27–31
Flemming RG, Capelli CC, Cooper SL, Proctor RA (2000) Bacterial colonization of functionalized polyurethanes. Biomaterials 21:273–281
Foster TJ (2005) Immune evasion by Staphylococci. Nat Rev Microbiol 3:948–958
Fountain MW, Weiss SJ, Fountain AG, Shen A, Lenk RP (1985) Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. J Infect Dis 152:529–535
Francolini I, Donelli G (2009) Eurobiofilms 2009. Abstract book, First European Congress on microbial biofilms, Rome, 2–5 Sept 2009, p 63
Francolini I, Norris P, Piozzi A, Donelli G, Stoodley P (2004) Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother 48(11):4360–4365
Francolini I, D’Ilario L, Guaglianone E, Donelli G, Martinelli A, Piozzi A (2010) Polyurethane anionomers containing metal ions with antimicrobial properties: thermal, mechanical and biological characterization. Acta Biomater 6(9):3482–3490
Francolini I, Crisante F, Martinelli A, D’Ilario L, Piozzi A (2012) Synthesis of biomimetic segmented polyurethanes as antifouling biomaterials. Acta Biomater 8(2):549–558
Francolini I, Donelli G, Vuotto C, Baroncini FA, Stoodley P, Taresco V, Martinelli A, D’Ilario L, Piozzi A (2014) Antifouling polyurethanes to fight device-related staphylococcal infections: synthesis, characterization, and antibiofilm efficacy. Pathog Dis 70(3):401–407
Freiberg S, Zhu XX (2004) Polymer microspheres for controlled drug release. Int J Pharm 282:1–18
Fux CA, Stoodley P, Hall-Stoodley L, Costerton JW (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1:667–683
Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40
Gad F, Zahra T, Hasan T, Hamblin MR (2000) Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother 48:2173–2178
Galdbart JO, Branger C, Andreassian B, Lambert-Zechovsky N, Kitzis M (1996) Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J Surg Res 66:174–178
Gallin JI (1983) Recent advances in chronic glaucomatous disease. Ann Intern Med 99:657–674
Garvin KL, Miyano JA, Robinson D, Giger D, Novak J, Radio S (1994) Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. J Bone Joint Surg 76:1500–1506
Gatter N, Kohnen W, Jansen B (1998) In vitro efficacy of hydrophilic central venous catheter loaded with silver to prevent microbial colonization. Zentralbl Bakteriol 287(1–2):157–169
George SJ, Vuddamalay P, Boscoe MJ (1997) Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 14(4):428–431
Gerhart TN, Roux RF, Horowitz G, Miller RL, Hanff P, Hayes WC (1988) Antibiotic release from an experimental biodegradable bone cement. J Orthop Res 6:585–592
Gindy ME, Prud’homme RK (2009) Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 6:865–878
Goldschmidt H, Hahn U, Salwender HJ, Haas R, Jansen B, Wolbring P, Rinck M, Hunstein W (1995) Prevention of catheter-related infection by silver coated central venous catheter in oncological patients. Zentralbl Bakteriol 283(2):215–223
Gordon JM, Walker CB (1993) Current status of systemic antibiotic usage in destructive periodontal disease. J Periodontal 64:760–771
Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, Gunsel A, Kemper FH, Winkelmann W, Von Eiff C (2004) Silver-coated megaendoprostheses in a rabbit model: an analysis of the infection rate and toxicological side effect. Biomaterials 25(24):5547–5556
Guha-Chowdhury N, Iwami Y, Yamada T (1997a) Effect of low levels of fluoride on proton excretion and intracellular pH in glycolysing streptococcal cells under strictly anaerobic conditions. Caries Res 31:373–378
Guha-Chowdhury N, Clark AG, Sissons CH (1997b) Inhibition of purified enolases from oral bacteria by fluoride. Oral Microbiol Immunol 12:91–97
Gupta CM, Haq W (2005) Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections. Methods Enzymol 391(Spec. Issue):291–304
Gürsel I, Korkusuz F, Türesin F, Alaeddinoglu NG, Hasirci V (2001) In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22:73–80
Gursel I, Yagmurlu F, Korkusuz F, Hasirci V (2002) In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul 19:153–164
Hanan MS, Riad EM, El-Khouly NA (2000) Antibacterial efficacy and pharmacokinetic studies of ciprofloxacin on Pasteurella multocida infected rabbits. Dtsch Tierarztl Wochenschr 107:151–155
Hannan M, Juste RN, Umasankar S, Glendenning A, Nightingale C, Azadian B, Soni N (1999) Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 54(9):868–872
Hanssen AD (2004) Prophylactic use of antibiotic bone cement: an emerging standard-in opposition [comment]. J Arthroplast 19(4 Suppl 1):73–77
Harris JM, Martin NE, Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40:539–551
Hasegawa M, Sudo A, Komlev VS, Barinov SM, Uchida A (2004) High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution. J Biomed Mater Res 70B:332–339
Heard SO, Wagle M, Vijayakumar E, McClean S, Brueggemann A, Napolitano LM, Edwards LP, O’Connell FM, Puyana JC, Doern GV (1998) Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 158(1):81–87
Heasman PA, Seymour RA (1994) Pharmacological control of periodontal disease I. Antiplaque Agents J Dent 22:323–335
Hendricks KJ, Lane DL, Burd TA, Lowry KJ, Day D, Phaup JG, Anglen JO (2001) Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clin Orthop 392:418–426
Hernandez-Caselles T, Villalain J, Gomez-Fernandez JC (1993) Influence of liposome charge and composition on their interaction with human blood serum proteins. Mol Cell Biochem 120:119–126
Hettfleisch J, Schottle H (1993) Local preventive antibiotic treatment in intramedullary nailing with gentamycin impregnated biomaterials. Aktuelle Traumatol 23(2):68–71
Hill KJ, Kaszuba M, Creeth JE, Jones MN (1997) Reactive liposomes encapsulating a glucose oxidase-peroxidase system with antibacterial activity. Biochim Biophys Acta Biomembr 1326(1):37–46
Høiby N (2002) Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros 1(4):249–254
Holmes B, Quie PG, Windhorst DB, Pollara B, Good RA (1966) Protection of phagocytized bacteria from the killing action of antibiotics. Nature 11:1131–1133
Holtom PD, Patzakis MJ (2003) Newer methods of antimicrobial delivery for bone and joint infections. Instr Course Lect 52:745–749
Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB (2007) Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 86:618–622
Jacob E, Setterstrom JA, Bach DE, Heath JR III, McNiesh LM, Cierny G III (1991) Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis. Clin Orthop 267:237–244
Jain G, Allon M, Saddekni S, Barker-Finkel J, Maya ID (2009) Does heparin coating improve patency or reduce infection of tunneled dialysis catheters? Clin J Am Soc Nephrol 4:1787–1790
Jamal MA, Rosenblatt JS, Hachem RY, Ying J, Pravinkumar E, Nates JL, Chaftari AM, Raad II (2014) Prevention of biofilm colonization by gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother 58(2):1179–1182
Jansen B, Kohnen W (1995) Prevention of biofilm formation by polymer modification. J Ind Microbiol 15(4):391–396
Jansen B, Peters G (1991) Modern strategies in the prevention of polymer-associated infections. J Hosp Infect 19(2):83–88
Jansen B, Schareina S, Steinhauser H (1987) Development of polymers with antiinfective properties. Polym Mater Sci Eng 57:43–46
Jansen B, Jansen S, Peters G, Pulverer G (1992) In vitro efficacy of a central venous catheter (‘Hydrocath’) loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 22(2):93–107
Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T (1994) In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 9(1):55–70
Johnson JR, Delavari P, Azar M (1999) Activities of a nitrofurazone containing urinary catheter and a silver hydrogel catheter against multidrug resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother 43:2990–2995
Johnson JR, Kuskowski MA, Wilt TJ (2006) Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 144(2):116–126
Jones MN (2005) Use of liposomes to deliver bactericides to bacterial biofilms. Methods Enzymol 391:211–228
Jones MN, Song YH, Kaszuba M, Reboiras MD (1997) The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides. J Drug Target 5:25–34
Jones N, Ray B, Ranjit KT, Manna AC (2008) Antibacterial activity of ZnO nanoparticles suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 279:71–76
Kabanov A, Batrakova E, Alakhov V (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189–212
Kamal GD, Pfaller MA, Rempe LE, Jebson PJ (1991) Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 265(18):2364–2368
Kamal GD, Divishek D, Kumar GC, Porter BR, Tatman DJ, Adams JR (1998) Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in a surgical intensive care unit. Diagn Microbiol Infect Dis 30(3):145–152
Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK (2007) The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117(4):877–888
Kanellakopoulou K, Kolia M, Anastassiadis A, Korakis T, Giamarellous-Bourboulis EJ, Andreopoulos A, Dounis E, Giamarellou H (1999) Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study. Antimicrob Agents Chemother 43:714–716
Kanellalopoulou K, Giamarellos-Bourboulis EJ (2000) Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59:1223–1232
Kaplan JB (2009) Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 32:545–554
Kaplan JB, Ragunath C, Ramasubbu N, Fine DH (2003) Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J Bacteriol 185:4693–4698
Kelly HM, Deasy PB, Ziaka E, Claffey N (2004) Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int J Pharm 274:167–183
Keogh BS, Triplett RG, Aufdemorte TB, Boyan BD (1989) The effect of local antibiotics in treating chronic osseous Staphylococcus aureus infection. J Oral Maxillofac Surg 47:940–945
Kim HJ, Jones MN (2004) The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J Liposome Res 14(3–4):123–139
Kim HJ, Gias M, Jones MN (1999) The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf A Physicochem Eng Asp 149:561–570
Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M (2004) Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release 98:47–56
Kim J, Pitts B, Stewart PS, Camper A, Yoon J (2008) Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm. Antimicrob Agents Chemother 52:1446–1453
Kingston D, Seal DV, Hill ID (1986) Self-dispersing plastics for intravenous catheters and prosthetic inserts. J Hyg Lond 96(2):185–198
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237
Kohnen W, Jansen B (2000) Changing material surface chemistry for preventing bacterial adhesion. In: An YH, Friedman RJ (eds) Handbook of bacterial adhesion. Humana Press, Totowa, pp 581–589
Koort JK, Suokas E, Veiranto M, Mäkinen TJ, Jalava J, Törmälä P, Aro HT (2006) In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res 78A:532–540
Krasko MY, Golenser J, Nyska A, Nyska M, Brin YS, Domb AJ (2007) Gentamicin extended release from an injectable polymeric implant. J Control Release 117:90–96
Kuhlmann J, Schaefer HG, Beermann D (1998) Clinical pharmacology. In: Kuhlmann J, Dalhoff A, Zeiler HJ (eds) Quinolone antibacterials, handbook of experimental pharmacology, vol 127. Springer, Berlin, pp 339–406
Le Rey AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi A, Merle C (2003) Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 24:443–449
Lee SH, Lee JE, Baek WY, Lim JO (2004) Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistance Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo. J Control Release 96:1–7
Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009) Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30:5969–5978
Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E (2012a) Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomedicine 7:1175–1188
Lellouche J, Friedman A, Lellouche JP, Gedanken A, Banin E (2012b) Improved antibacterial and antibiofilm activity of magnesium fluoride nanoparticles obtained by water-based ultrasound chemistry. Nanomedicine 8(5):702–711
Letsch R, Rosenthal E, Joka T (1993) Local antibiotic administration in osteomyelitis treatment-a comparative study with two different carrier substances. Aktuelle Traumatol 23(7):324–329
Li LC, Deng J, Stephens D (2002) Polyanhydride implant for antibiotic delivery-from the bench to the clinic. Adv Drug Deliv Rev 54:963–986
Liliana A, Jan W, Robert WW, Micheal S (2008) Drug eluting medical devices having porous layers. US 2008070842A1
Lin J, Qui S, Lewis K, Klibanov AM (2002) Bactericidal properties of flat surfaces and nanoparticles derivatized with alkylated polyethylenimines. Biotechnol Prog 18:1082–1086
Liu WK, Tebbs SE, Byrne PO, Elliott TS (1993) The effect of electric current on bacteria colonising intravenous catheters. J Infect 27(3):261–269
Logghe C, Van Ossel C, D’Hoore W, Ezzedine H, Wauters G, Haxhe JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 37(2):145–156
Lowery A, Strojny J, Puleo J, Division of Small Manufacturers Assistance, Office of Health and Industry Programs (1996) Medical device quality systems manual: a small entity compliance guide, 1st edn. HHS Publication FDA 97-4179. Center for Devices and Radiological Health (CDRH), Food and Drug Administration, US Department of Health and Human Services, Rockville. Available from: http://www.gmp-compliance.org/guidemgr/files/MDQS.MANUAL.PDF. Accessed 11 Nov 2013
Mader JT, Calhoun J, Cobos J (1997) In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmetacrylate beads. Antimicrob Agents Chemother 41:415–418
Mader JT, Stevens CM, Stevens JH, Roble R, Lathrop JT, Calhoun JH (2002) Treatment of experimental osteomyelitis with a fibrin sealant antibiotic implant. Clin Orthop 403:58–72
Majumdar S, Flasher D, Friend DS, Nassos P, Yajko D, Hadley WK, Duzgunes N (1992) Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-Mycobacterium intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob Agents Chemother 36:2808–2815
Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296(23):1305–1309
Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 127(4):257–266
Mäkinen TJ, Veiranto M, Lankinen P, Moritz N, Jalava J, Törmälä P, Aro HT (2005) In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063–1068
Marquis RE (1995) Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol 41:955–964
Marquis RE, Clock SA, Mota-Meira M (2003) Fluoride and organic weak acids as modulators of microbial physiology. FEMS Microbiol Rev 26:493–510
Martinez LR, Casadevall A (2005) Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73(10):6350–6362
McDermott RP (1994) Inflammatory bowel disease. Curr Opin Gastroenterol 10:355–357
McKee MD, Wild LM, Schemitsch EH, Waddell JP (2002) The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthop Trauma 16(9):622–627
Mclean RJ, Hussain AA, Sayer M, Vincent PJ, Hughes DJ, Smith TJ (1993) Antibacterial activity of multilayer silver-copper surface film on catheter material. Can J Microbiol 39(9):895–899
Miceli MH, Bernardo SM, Lee SA (2009) In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34:326–332
Miyazaki S, Tobiyama T, Takada M, Attwood D (1995) Percutaneous absorption of indomethacin from pluronic F 127 gels in rats. J Pharm Pharmacol 47:455–457
Moses MA, Brem H, Langer R (2003) Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 4:337–341
Mysorekar IU, Hultgren SJ (2006) Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci 103:14170–14175
Nace V (1996) Nonionic surfactants: polyoxyalkylene block copolymers. Marcel Dekker, New York
Nelson CL, Hickmon SG, Harrison BH (1994) Elution characteristics of gentamicin-PMMA beads after implantation in humans. Orthopedics 17(5):415–416
Nelson CL, McLaren SG, Skinner RA, Smeltzer MS, Thomas JR, Olsen KM (2002) The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 20:643–647
Neumann PJ, Tunis SR (2010) Medicare and medical technology-the growing demand for relevant outcomes. N Engl J Med 362(5):377–379
Nie L, Nicolau DP, Nightingale CH, Browner BD, Quintiliani R (1995) In vitro elution of ofloxacin from a bioabsorbable polymer. Acta Orthop Scand 66:365–368
Nightingale SD, Saletan SL, Swenson CE, Lawrence AJ, Watson DA, Pilkiewicz FG, Silverman EG, Cal SX (1993) Liposome encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob Agents Chemother 37:1869–1872
Nix DE, Goodwin D, Peloquin CA, Rotella DL, Schentag JJ (1991) Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob Agents Chemother 35:1947–1950
Nolan PC, Wilson DJ, Mollan RA (1993) Calcium hydroxyapatite ceramic delivery system. J Bone Joint Surg 75:600–604
Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL (2008) Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett 8:302–306
O’Keeffe K (2011) The rise of medtech (webpage on the Internet). (cited 2 Jan 2012). Available from: http://www.mddionline.com/article/rise-medtech. Accessed 7 Apr 2014
O’Neill JF, Hope CK, Wilson M (2002) Oral bacteria in multispecies biofilms can be killed by red light in the presence of toluidine blue. Lasers Surg Med 31:86–90
Oda T, Hamasaki J, Kanda N, Mikami K (1997) Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter [published erratum appears in Anesthesiology 1998 Feb 88 (2): 560]. Anesthesiology 87(5):1242–1244
Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD (2007) Periodontal disease at the biofilm-gingival interface. J Periodontol 78(10):1911–1925
Oja CD, Semple SC, Chonn A, Cullis PR (1996) Influence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta 1281:31–37
Oku N, Tokudome Y, Namba Y, Saito N, Endo M, Hasegawa Y, Kawai M, Tsukada H, Okda S (1996) Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Biochim Biophys Acta 1280:149–154
Otto M (2004) Quorum-sensing control in Staphylococci-A target for antimicrobial drug therapy? FEMS Microbiol Lett 241:135–141
Overbeck JP, Winckler ST, Meffert R, Törmälä P, Spiegel HU, Brug E (1995) Penetration of ciprofloxacin into bone: a new bioabsorbable implant. J Invest Surg 8:155–162
Pandit JK (1997) Targeted devices for periodontal diseases. In: Jain NK (ed) Controlled drug delivery. CBS Publishers and distributors, New Delhi, pp 130–146
Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142
Pasquaroli S, Zandri G, Vignaroli C, Vuotto C, Donelli G, Biavasco F (2013) Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. J Antimicrob Chemother 68(8):1812–1817
Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E (1996) No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 131(9):986–989
Pettit RK, Weber CA, Lawrence SB, Pettit GR, Kean MJ, Cage GD (2009) In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Med Microbiol 58:1203–1206
Pickering SAW, Bayston R, Scanlin TF (2003) Electromagnetic augmentation of antibiotic efficacy in infection of orthopaedic implants. J Bone Joint Surg Br 85B:588–593
Pinto-Alphandary H, Andremont A, Couvreur P (2000) Targeted delivery of antibiotics using liposomes and nanoparticles: research and implications. Int J Antimicrob Agents 13:155–168
Piozzi A, Francolini I, Occhiaperti L, Venditti M, Marconi W (2004) Antimicrobial activity of polyurethanes coated with antibiotics: a new approach to the realization of medical devices exempt from microbial colonization. Int J Pharm 280(1–2):173–183
Pitt WG, Ross SA (2003) Ultrasound increases the rate of bacterial growth. Biotechnol Prog 19:1038–1044
Polisena J, Jutai J, Chreyh R (2014) A proposed framework to improve the safety of medical devices in a Canadian hospital context. Med Devices Evid Res 7:139–147
Post JC, Hiller NL, Nistico L, Stoodley P, Ehrlich GD (2007) The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 15(5):347–351
Pugach JL, DiTizio V, Mittelman MW, Bruce AW, DiCosmo F, Khoury AE (1999) Antibiotic hydrogel coated Foley catheters for prevention of urinary tract infection in a rabbit model. J Urol 162:883–887
Quesnel LB, Al Najjar AR, Buddhavudhikrai P (1978) Synergism between chlorhexidine and sulphadiazine. J Appl Bacteriol 45:397–405
Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP (1995) Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39:2397–2400
Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP (1996a) The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173(2):418–424
Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP (1996b) Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 173:495–498
Raad I, Hachem R, Zermeno A, Dumo M, Bodey GP (1996c) In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 17(11):1055–1059
Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ (1997a) Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 25:149–151
Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C (1997b) Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial, The Texas Medical Center Catheter Study Group. Ann Intern Med 127(4):267–274
Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51:1656–1660
Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R (2008) Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother 62:746–750
Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY (2012) Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 56(2):935–941
Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–796
Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W (2000) Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 44:3357–3363
Ranucci M, Isgro G, Giomarelli PP, Pavesi M, Luzzani A, Cattabriga I, Carli M, Giomi P, Compostella A, Digito A, Mangani V, Silvestri V, Mondelli E (2003) Catheter Related Infection Trial (CRIT) Group, impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31(1):52–59
Raoult MM (1996) Optimum treatment of intracellular infection. Drugs 52:45–59
Raschke MJ, Schmidmaier G (2004) Biological coating of implants in trauma and orthopedic surgery. Unfallchirurg 107:653–663
Rastogi N, Blom Potar MC (1990) Intracellular bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis H37Rv multiplying in the J-775 macrophage cell line. Zentralbl Bakteriol 273:195–199
Rediske AM, Roeder BL, Nelson JL, Robison RL, Schaalje GB, Robison RA (2000) Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 44:771–772
Reisner A, Høiby N, Tolker-Nielsen T, Molin S (2005a) Microbial pathogenesis and biofilm development. Contrib Microbiol 12:114–131
Reisner A, Høibyb N, Tolker-Nielsena T, Molina S (2005b) Microbial pathogenesis and biofilm development. In: Russell W, Herwald H (eds) Concepts in bacterial virulence, vol 12, Contributions to microbiology. Karger, Basel, pp 114–131
Richardson RL Jr, Pate JW, Wolf RY, Ledes C, Hopson WB Jr (1970) The outcome of antibiotic-soaked arterial grafts in guinea pig wounds contaminated with E. coli or S. aureus. J Thorac Cardiovasc Surg 59:635–637
Robinson AM, Bannister M, Creeth JE, Jones MN (2001) The interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericide. Colloids Surf A Physicochem Eng Asp 186:43–53
Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB (2008) Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61:869–876
Romano G, Berti M, Goldstein BP, Borghi A (1993) Efficacy of a central venous catheter (‘Hydrocath’) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse. Zentral Bakteriol 279(3):426–433
Ross S, Robert M, Harvey MA, Farrell S, Schulz J, Wilkie D, Lovatsis D, Epp A, Easton B, McMillan B, Schachter J, Gupta C, Weijer C (2008) Ethical issues associated with the introduction of new surgical devices, or just because we can, doesn’t mean we should. J Obstet Gynaecol Can 30(6):508–513
Rous P, Jones FS (1916) The protection of pathogenic microorganisms by living tissue cells. J Exp Med 23:601–605
Ruggeri V, Francolini I, Donelli G, Piozzi A (2007) Synthesis, characterization, and in vitro activity of antibiotic releasing polyurethanes to prevent bacterial resistance. J Biomed MaterRes A 81:287–298
Russell PB, Kline J, Yoder MC, Polin RA (1987) Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependent and enhanced by fibronectin. J Clin Microbiol 25:1083–1087
Rutala WA, Weber DJ (1997) Use of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 10:597–610
Saito T, Takeuchi R, Hirakawa K, Nagata N, Yoshida T, Koshino T, Okuda K, Takema M, Hori T (2002) Slow-releasing potential of vancomycin-loaded porous hydroxyapatite blocks implanted into MRSA osteomyelitis. J Biomed Mater Res 63:245–251
Salem II, Flasher DL, Düzgüneş N (2005) Liposome-encapsulated antibiotics. Methods Enzymol 391(Spec. Iss.):261–291
Sapra P, Allen TM (2003) Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 42:439–462
Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40:257–262
Schierholz JM, Fleck C, Beuth J, Pulverer G (2000) The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 46(1):45–50
Schlapp M, Friess W (2003) Collagen/PLGA microparticle controlled composites for local delivery of gentamicin. J Pharm Sci 92:2145–2151
Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M (2006) Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37(Suppl 2):S105–S112
Schwach-Abdellaoni K, Vivien-Castioni N, Gurny R (2000) Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 50:83–99
Sehulster L, Chinn RYW (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Centers for Disease Control and Prevention. MMWR Recomm Rep 52(RR-10):1–42
Semple SC, Chonn A, Cullis PR (1998) Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behavior in vivo. Adv Drug Deliv Rev 32:3–17
Senior J, Trimble KR, Maskiewicz R (1991) Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim Biophys Acta 1070:173–179
Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT (2000) Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 38(1):1–5
Sheretz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD (1993) Efficacy of antibiotic- coated catheters in preventing subcutaneous Staphylococcus aureus infection. J Infect Dis 167:98–106
Shi ZL, Neoh KG, Kang ET, Wang W (2006) Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials 27:2440–2449
Shirtliff ME, Calhoun JH, Mader JT (2002) Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin Orthop 401:239–247
Sinha VR, Trehan A (2003) Biodegradable microspheres for protein delivery. J Control Release 90:261–280
Sioshansi P (1994) New processes for surface treatment of catheters. Artif Organs 18(4):266–271
Sloan JM, Cameron CH, Maxwell RJ, McCluskey DR, Collins JS (1996) Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut 38:619–622
Solberg BD, Gutow AP, Baumgaertner MR (1999) Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 13:102–106
Solovskij MV, Ulbrich K, Kopecek J (1983) Synthesis of N-(2- hydroxypropyl)methacrylamide copolymers with antimicrobial activity. Biomaterials 4(1):44–48
Soukos NS, Socransky SS, Mulholland SE, Lee S, Doukas AG (2000) Photomechanical drug delivery into bacterial biofilms. Pharm Res 17:405–419
Srinivasan A, Karchmer T, Richards A, Song X, Perl TM (2006) A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 27(1):38–43
Stemberger A, Grimm H, Bader F, Rahn HD, Ascherl R (1997) Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg 578:17–26
Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292:107–113
Stewart PS, Wattanakaroon W, Goodrum L, Fortun SM, McLeod BR (1999) Electrolytic generation of oxygen partially explains electrical enhancement of tobramycin efficacy against Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother 43:292–296
Stoiser B, Kofler J, Staudinger T, Georgopoulos A, Lugauer S, Guggenbichler JP, Burgmann H, Frass M (2002) Contamination of central venous catheters in immunocompromised patients; a comparison between two different types of central venous catheters. J Hosp Infect 50(3):202–206
Sturr MG, Marquis RE (1990) Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum. Arch Microbiol 155:22–27
Tambe SM, Sampath L, Modak SM (2001) In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 47(5):589–598
Tamilvanan S, Venkateshan N, Ludwig A (2008) The potential of lipid-and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release 128(1):2–22
Tattawasart U, Maillard JY, Furr JR, Russell AD (1999) Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 42(3):219–229
Tauber AL, Borregaard N, Simon E, Wright J (1963) Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine 62:286
Taylor EN, Webster TJ (2009) The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine 4:145–152
Taylor GJ, Bannister GC, Calder S (1990) Perioperative wound infection in elective orthopaedic surgery [published erratum appears in J Hosp Infect 1991 Feb; 17(2):155]. J Hosp Infect 16(3):241–247
Tebbs SE, Elliott TSJ (1993) A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J Antimicrob Chemother 31:261–271
Tebbs SE, Elliott TS (1994) Modification of central venous catheter polymers to prevent in vitro microbial colonization. Eur J Clin Microbiol Infect Dis 13(2):111–117
Tebbs SE, Sawyer A, Elliott TS (1994) Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 72(5):587–591
Tennenberg S, Lieser M, McCurdy B, Boomer G, Howington E, Newman C, Wolf I (1997) A prospective randomized trial of an antibiotic-and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 132(12):1348–1351
van den Broek PJ (1989) Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 11:213–245
Varde NK, Pack DW (2004) Microspheres for controlled drug delivery. Expert Opin Biol Ther 4:35–51
Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B (1999) Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm 192:183–193
Vincent C, Neale G, Woloshynowych M (2001) Adverse events in British hospitals: preliminary retrospective record review. BMJ 322(7285):517–519
Wahlig H, Buchholz HW (1972) Experimental and clinical studies on the release of gentamicin from bone cement. Chirurg 43:441–445
Wainwright M, Crossley KB (2004) Photosensitising agents-circumventing resistance and breaking down biofilms: a review. Int Biodeterior Biodegrad 53:119–126
Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon S-H, Ikada Y (1991) A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. J Bone Joint Surg 73:246–252
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Cumutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 79:155–169
Wong JP, Yuang H, Blasetti KL, Schnell G, Conley J, Schofield LN (2003) Liposome delivery of ciprofloxacin against Francisella tularensis infection. J Control Release 92:265–273
Woo GL, Yang ML, Yin HQ, Jaffer F, Mittelman MW, Santerre JP (2002) Biological characterization of a novel biodegradable antimicrobial polymer synthesized with fluoroquinolones. J Biomed Mater Res 59(1):35–45
Wright KJ, Seed PC, Hultgren SJ (2005) Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 73:7657–7668
Xie J, Huang J, Li X, Sun S, Chen X (2009) Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem 16:1278–1294
Yenice I, Çalis S, Kas HS, Ozalp M, Ekizoglu M, Hincal AA (2002) Biodegradable implantable teicoplanin beads for the treatment of bone infections. Int J Pharm 242:271–275
Yenice I, Çalis S, Atilla B, Kas HS, Ozalp M, Ekizoglu M, Bilgili H, Hincal AA (2003) In vitro/in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects. J Microencapsul 20:705–717
Yoo JY, Kim JM, Khang G, Kim MS, Cho SH, Lee HB, Kim YS (2004) Effect of lactide/glycolide monomers on release behaviours of gentamicin sulfate-loaded PLGA discs. Int J Pharm 276:1–9
Zhang X, Wyss UP, Pichora D, Goosen MF (1994) Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J Pharm Pharmacol 46:718–724
Zhao Z, Wang J, Mao HQ, Leong KW (2003) Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev 55:483–499
Zilberman M, Elsner JJ (2008) Antibiotic-eluting medical devices for various applications. J Control Release 130:202–215
Zilberman M, Malka A (2009) Drug controlled release from structured bioresorbable films used in medical devices-a mathematical model. J Biomed Mater Res B Appl Biomater 89:155–164
Zilberman M, Shifrovitch Y, Aviv M, Hershkovitz M (2009) Structured drug-eluting bioresorbable films: microstructure and release profile. J Biomater Appl 23:385–406
Zulianello L, Meda P (2009) Rhamnose antagonists and use thereof. WO/2009/040726
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Shunmugaperumal, T., Kaur, V., Thenrajan, R.S. (2015). Lipid- and Polymer-Based Drug Delivery Carriers for Eradicating Microbial Biofilms Causing Medical Device-Related Infections. In: Donelli, G. (eds) Biofilm-based Healthcare-associated Infections. Advances in Experimental Medicine and Biology, vol 831. Springer, Cham. https://doi.org/10.1007/978-3-319-09782-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-09782-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09781-7
Online ISBN: 978-3-319-09782-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)